Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome

  • Dogan, Esra Sinem Kemer (Department of Periodontology, Mustafa Kemal University Faculty of Dentistry) ;
  • Dogan, Burak (Department of Periodontology, Mustafa Kemal University Faculty of Dentistry) ;
  • Fentoglu, Ozlem (Department of Periodontology, Suleyman Demirel University Faculty of Dentistry) ;
  • Kirzioglu, Fatma Yesim (Department of Periodontology, Suleyman Demirel University Faculty of Dentistry)
  • Received : 2019.02.23
  • Accepted : 2019.04.14
  • Published : 2019.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: An unresolved inflammatory state contributes to the pathogenesis of periodontal disease and metabolic syndrome (MetS). Therefore, the purpose of this study was to evaluate the role of lipoxin A4 (LXA4), a proresolving lipid mediator, in the association between periodontal disease and MetS. Methods: Sixty-seven patients with MetS and 65 patients without MetS were included in the study. Sociodemographic information was obtained via a questionnaire, and detailed medical diagnoses were made. Periodontal parameters (plaque index [PI], gingival index [GI], probing pocket depth [PD], and clinical attachment level [CAL]) and metabolic parameters were measured, and serum LXA4 levels were determined. The associations among MetS, periodontal parameters, and serum LX levels were evaluated by adjusted multivariate linear regression analyses. Results: Patients with MetS were older and had a higher body mass index than patients without MetS. Periodontal parameters (PI, GI, PD, and CAL) were higher in patients with MetS than in those without MetS. Serum LXA4 levels were higher in patients without MetS. Multivariate linear regression analysis indicated a positive association between MetS and periodontal parameters (PD and CAL). Negative associations were established between MetS and LXA4 levels, and between LXA4 and periodontal parameters (PI, PD, and CAL). Conclusions: The presence of higher values of periodontal parameters in patients with MetS and the negative relationship of LXA4 with MetS and periodontal disease may support the protective role of proresolving lipid mediators in the association between periodontal disease and MetS.

Keywords

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. https://doi.org/10.1001/jama.285.19.2486
  2. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015;15:30-44. https://doi.org/10.1038/nri3785
  3. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008;117:3118-25. https://doi.org/10.1161/CIRCULATIONAHA.107.758524
  4. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013;40 Suppl 14:S113-34. https://doi.org/10.1111/jcpe.12059
  5. Khader Y, Khassawneh B, Obeidat B, Hammad M, El-Salem K, Bawadi H, et al. Periodontal status of patients with metabolic syndrome compared to those without metabolic syndrome. J Periodontol 2008;79:2048-53. https://doi.org/10.1902/jop.2008.080022
  6. Fukui N, Shimazaki Y, Shinagawa T, Yamashita Y. Periodontal status and metabolic syndrome in middle-aged Japanese. J Periodontol 2012;83:1363-71. https://doi.org/10.1902/jop.2012.110605
  7. Nibali L, Tatarakis N, Needleman I, Tu YK, D'Aiuto F, Rizzo M, et al. Clinical review: association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 2013;98:913-20. https://doi.org/10.1210/jc.2012-3552
  8. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res 2007;86:271-5. https://doi.org/10.1177/154405910708600314
  9. Li P, He L, Sha YQ, Luan QX. Relationship of metabolic syndrome to chronic periodontitis. J Periodontol 2009;80:541-9. https://doi.org/10.1902/jop.2009.080387
  10. Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N, et al. A cohort study on the association between periodontal disease and the development of metabolic syndrome. J Periodontol 2010;81:512-9. https://doi.org/10.1902/jop.2010.090594
  11. Thanakun S, Watanabe H, Thaweboon S, Izumi Y. Association of untreated metabolic syndrome with moderate to severe periodontitis in Thai population. J Periodontol 2014;85:1502-14. https://doi.org/10.1902/jop.2014.140105
  12. Watanabe K, Cho YD. Periodontal disease and metabolic syndrome: a qualitative critical review of their association. Arch Oral Biol 2014;59:855-70. https://doi.org/10.1016/j.archoralbio.2014.05.003
  13. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006;33:401-7. https://doi.org/10.1111/j.1600-051X.2006.00924.x
  14. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. J Periodontal Res 2009;44:43-51. https://doi.org/10.1111/j.1600-0765.2007.01060.x
  15. Rizzo M, Cappello F, Marfil R, Nibali L, Marino Gammazza A, Rappa F, et al. Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. Cell Stress Chaperones 2012;17:399-407. https://doi.org/10.1007/s12192-011-0315-1
  16. Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II. Clin Lipidol 2013;8:465-80. https://doi.org/10.2217/clp.13.32
  17. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003;82:82-90. https://doi.org/10.1177/154405910308200202
  18. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory--pro-resolving mediators and their receptors. Curr Top Med Chem 2011;11:629-47. https://doi.org/10.2174/1568026611109060629
  19. El Kebir D, Jozsef L, Pan W, Wang L, Petasis NA, Serhan CN, et al. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med 2009;180:311-9. https://doi.org/10.1164/rccm.200810-1601OC
  20. Yu D, Xu Z, Yin X, Zheng F, Lin X, Pan Q, et al. Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population. PLoS One 2015;10:e0142848. https://doi.org/10.1371/journal.pone.0142848
  21. Dogan B, Fentoglu O, Kirzioglu FY, Kemer ES, Koroglu BK, Aksu O, et al. Lipoxin A4 and neutrophil/lymphocyte ratio: a possible indicator in achieved systemic risk factors for periodontitis. Med Sci Monit 2015;21:2485-93. https://doi.org/10.12659/MSM.895115
  22. Tarannum F, Faizuddin M. Association between lipoxin A4 and interleukin-12 in gingival crevicular fluid: a preliminary investigation. J Periodontal Res 2017;52:210-7. https://doi.org/10.1111/jre.12383
  23. Lutfioglu M, Aydogdu A, Sakallioglu EE, Alacam H, Pamuk F. Gingival crevicular fluid interleukin-8 and lipoxin A4 levels of smokers and nonsmokers with different periodontal status: a cross-sectional study. J Periodontal Res 2016;51:471-80. https://doi.org/10.1111/jre.12324
  24. Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, et al. Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res 2015;94:148-56. https://doi.org/10.1177/0022034514557331
  25. Borgeson E, Lonn J, Bergstrom I, Brodin VP, Ramstrom S, Nayeri F, et al. Lipoxin A4 inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. Infect Immun 2011;79:1489-97. https://doi.org/10.1128/IAI.00777-10
  26. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-65. https://doi.org/10.4049/jimmunol.171.12.6856
  27. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-35. https://doi.org/10.3109/00016356408993968
  28. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-51. https://doi.org/10.3109/00016356309011240
  29. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. https://doi.org/10.1902/annals.1999.4.1.1
  30. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894. Geneva: World Health Organization; 2000.
  31. Ahn YB, Shin MS, Byun JS, Kim HD. The association of hypertension with periodontitis is highlighted in female adults: results from the Fourth Korea National Health and Nutrition Examination Survey. J Clin Periodontol 2015;42:998-1005. https://doi.org/10.1111/jcpe.12471
  32. Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J 2017;67:67-77. https://doi.org/10.1111/idj.12264
  33. Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014;19:21-36. https://doi.org/10.1016/j.cmet.2013.10.006
  34. Borgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, et al. Lipoxin A4 attenuates adipose inflammation. FASEB J 2012;26:4287-94. https://doi.org/10.1096/fj.12-208249
  35. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol 2008;79 Suppl:1601-8. https://doi.org/10.1902/jop.2008.080173
  36. Hasturk H, Kantarci A. Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 2015;69:255-73. https://doi.org/10.1111/prd.12105
  37. Morita T, Ogawa Y, Takada K, Nishinoue N, Sasaki Y, Motohashi M, et al. Association between periodontal disease and metabolic syndrome. J Public Health Dent 2009;69:248-53. https://doi.org/10.1111/j.1752-7325.2009.00130.x
  38. Kushiyama M, Shimazaki Y, Yamashita Y. Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol 2009;80:1610-5. https://doi.org/10.1902/jop.2009.090218
  39. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y. Periodontal disease as part of the insulin resistance syndrome in diabetic patients. J Int Acad Periodontol 2005;7:16-20.
  40. Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, et al. The severity of periodontitis and metabolic syndrome in Korean population: the Dong-gu study. J Periodontal Res 2018;53:362-8. https://doi.org/10.1111/jre.12521

Cited by

  1. ASSESSMENT OF METABOLIC AND HUMORAL BLOOD FACTORS IN PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS ASSOCIATED METABOLIC SYNDROME vol.2019, pp.4, 2019, https://doi.org/10.29254/2077-4214-2019-4-1-153-275-278
  2. Molecular identification and diversity analysis of dental bacteria in diabetic and non-diabetic females from Saudi Arabia vol.27, pp.1, 2019, https://doi.org/10.1016/j.sjbs.2019.10.005
  3. Lipid-Induced Mechanisms of Metabolic Syndrome vol.2020, 2020, https://doi.org/10.1155/2020/5762395
  4. Specialized PRORESOLVING mediators in infection and lung injury vol.47, pp.1, 2021, https://doi.org/10.1002/biof.1691
  5. Lipid Metabolism, Disorders and Therapeutic Drugs - Review vol.29, pp.6, 2019, https://doi.org/10.4062/biomolther.2021.122
  6. Evaluation of the association between periodontitis and risk of Parkinson’s disease: a nationwide retrospective cohort study vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-96147-4